カテゴリー： IMARC, 世界, 医療/バイオ

ナノエマルジョンの世界市場2022-2028：産業動向、シェア、規模、成長、機会・予測

◆英語タイトル：Nanoemulsion Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書（IMARC23FE0079）◆商品コード：IMARC23FE0079
◆発行会社（リサーチ会社）：IMARC
◆発行日：2023年2月1日
◆ページ数：143
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

IMARC社発行の当調査資料によると、2022年107億ドルであった世界のナノエマルジョン市場規模が2028年には181億ドルに達し、予測期間中、年平均8.63％成長すると予測されています。当書は、ナノエマルジョンの世界市場について総合的に調査・分析されたレポートです。序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（低分子界面活性剤、蛋白質安定化エマルション、多糖類）分析、投与経路別（経口、非経口、その他）分析、用途別（麻酔薬、抗生物質、非ステロイド性抗炎症薬、免疫抑制剤、その他）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東/アフリカ）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目がまとめられています。なお、当書に掲載されている企業情報には、Ascendia Pharmaceuticals、B. Braun Melsungen AG、BlueWillow Biologics Inc.、Covaris Inc.、Fresenius Kabi AG、IDEX Corporation、Kaken Pharmaceutical Co. Ltd.,Latitude Pharmaceuticals Inc.、Owen Biosciences Inc.、Santen Pharmaceutical Co. Ltd and Taiwan Liposome Co. Ltd.などが含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション

・世界のナノエマルジョン市場規模：種類別
- 低分子界面活性剤の市場規模
- 蛋白質安定化エマルションの市場規模
- 多糖類の市場規模

・世界のナノエマルジョン市場規模：投与経路別
- 経口投与の市場規模
- 非経口投与の市場規模
- その他投与経路の市場規模

・世界のナノエマルジョン市場規模：用途別
- 麻酔薬における市場規模
- 抗生物質における市場規模
- 非ステロイド性抗炎症薬における市場規模
- 免疫抑制剤における市場規模
- その他用途における市場規模

・世界のナノエマルジョン市場規模：地域別
- 北米のナノエマルジョン市場規模
- アジア太平洋のナノエマルジョン市場規模
- ヨーロッパのナノエマルジョン市場規模
- 中南米のナノエマルジョン市場規模
- 中東/アフリカのナノエマルジョン市場規模

・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況
・主要企業情報

The global nanoemulsion market size reached US$ 10.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 18.1 Billion by 2028, exhibiting a growth rate (CAGR) of 8.63% during 2023-2028.

Nanoemulsions are thermodynamically stable isotropic systems wherein two immiscible liquids are mixed using an emulsifying agent like surfactant and co-surfactant. They are safe, effective, non-toxic, and non-irritant and have small-sized droplets with a greater surface area that provide better absorption and improved physical stability. As a result, they are used as carriers of drug molecules in pharmaceutical systems to improve the delivery of active pharma ingredients. They also help protect drugs that are susceptible to hydrolysis and oxidation, enable prolonged action of the medicaments, and provide better uptake of oil-soluble supplements in cell culture technology.

Nanoemulsion Market Trends:
The rising prevalence of chronic diseases, along with increasing preferences for smart and precision drug delivery systems, represents one of the key factors catalyzing the demand for nanoemulsions worldwide. Moreover, nanoemulsions are used for targeted drug delivery of various anticancer drugs, photosensitizers, and therapeutic agents. In addition, as they can enhance the therapeutic efficacy of drugs and minimize adverse effects and toxic reactions, they are gaining traction over conventional drug delivery systems across the globe. Apart from this, the growing aging population, which is more susceptible to critical health disorders, is propelling the need for nanoemulsions to treat reticuloendothelial system (RES) infection and in the enzyme replacement therapy of the liver. Besides this, they are employed in the cosmetics and personal care industries to manufacture foams, creams, liquids, and sprays. Furthermore, increasing demand for functional food on account of the rising health consciousness among individuals is positively influencing the applications of nanoemulsions in the food and beverage (F&B) industry. They assist in improving the digestibility of food and the bioavailability of active components.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global nanoemulsion market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, route of administration and application.

Breakup by Type:

Small-molecule Surfactant
Protein-stabilized Emulsions
Polysaccharide

Breakup by Route of Administration:

Oral
Parenteral
Others

Breakup by Application:

Anesthetics
Antibiotics
Nonsteroidal Anti-inflammatory Drugs
Immunosuppressants
Steroids
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ascendia Pharmaceuticals, B. Braun Melsungen AG, BlueWillow Biologics Inc., Covaris Inc., Fresenius Kabi AG, IDEX Corporation, Kaken Pharmaceutical Co. Ltd., Latitude Pharmaceuticals Inc., Owen Biosciences Inc., Santen Pharmaceutical Co. Ltd and Taiwan Liposome Co. Ltd.

Key Questions Answered in This Report
1. What was the size of the global nanoemulsion market in 2022?
2. What is the expected growth rate of the global nanoemulsion market during 2023-2028?
3. What are the key factors driving the global nanoemulsion market?
4. What has been the impact of COVID-19 on the global nanoemulsion market?
5. What is the breakup of the global nanoemulsion market based on the type?
6. What is the breakup of the global nanoemulsion market based on the application?
7. What are the key regions in the global nanoemulsion market?
8. Who are the key players/companies in the global nanoemulsion market?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Nanoemulsion Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Small-molecule Surfactant
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Protein-stabilized Emulsions
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Polysaccharide
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Route of Administration
7.1 Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Parenteral
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Anesthetics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Antibiotics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Nonsteroidal Anti-inflammatory Drugs
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Immunosuppressants
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Steroids
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Other
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Ascendia Pharmaceuticals
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 B. Braun Melsungen AG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.3 BlueWillow Biologics Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Covaris Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Fresenius Kabi AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 IDEX Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Kaken Pharmaceutical Co. Ltd.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Latitude Pharmaceuticals Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Owen Biosciences Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Santen Pharmaceutical Co. Ltd
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Taiwan Liposome Co. Ltd.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ナノエマルジョンの世界市場2022-2028：産業動向、シェア、規模、成長、機会・予測(Nanoemulsion Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • モノクローナル抗体の世界市場2022-2028：産業動向、シェア、規模、成長、機会・予測
  • 血液悪性腫瘍の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • アルツハイマー病治療薬の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • オッセオインテグレーションインプラントの世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 臨床栄養の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測

    • ◆H&Iグローバルリサーチのお客様（例）◆